About us

Duearity is a Swedish innovative medical technology company with a vision to create products that make a positive difference for people suffering or bothered by tinnitus. Our first product is called Tinearity G1.

Tinearity G1 has its roots in founder Peter Arndt's personal experiences of suffering from tinnitus. After undergoing TRT treatment with CBT therapy and listening to "white noise" for many hours every day, Peter realized that the treatment needed to be improved to integrate more smoothly into everyday life.

With his experience in product development within medical technology and his role as CEO and co-owner of a product development company, Peter drove the idea of ​​developing an innovative and flexible tinnitus aid that emits white noise. The idea led to the product Tinearity G1.

With a focus on sustainability, health, and quality of life, the goal is to make life better for those who suffer or are bothered by tinnitus by offering a technical solution that makes a difference.

Our journey so far

Duearity's adventure began during an inspiring summer in 2020. It was then that we decided to revolutionize the treatment of tinnitus. In just three short years, we have turned the dream of Tinearity G1 into reality. This groundbreaking product now serves as a beacon of hope for those struggling with tinnitus.

Our success extends far beyond our rapid pace of development. Tinearity G1's medical technology classification and CE marking mean that this carefully crafted solution complies with EU regulations for medical devices. Additionally, the product has been approved for sale in the USA by the Food and Drug Administration (FDA) and in the UK (UKCA).

Tinearity G1 is unique as it is the only medical device in the world based on bone conduction technology and solely aims to alleviate and treat tinnitus. We are thus on track to achieve our vision of making a positive difference for people suffering or bothered by tinnitus.